MetaADEDB 2.0 @ LMMD
Lincomycin
(POUMFISTNHIPTI-DKEHCADZSA-N)
Structure
SMILES
CCC[C@H]1CN([C@@H](C1)C(=O)N[C@@H]([C@H]1O[C@H](SC)[C@@H]([C@H]([C@@H]1O)O)O)[C@H](O)C)C.Cl
Molecular Formula:
C18H35ClN2O6S
Molecular Weight:
442.998
Log P:
0.2738
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
6
TPSA:
147.79
CAS Number(s):
859-18-7
Synonym(s)
1.
Lincomycin
2.
Lincolnensin
3.
Lincomycin, (2S-cis)-Isomer
4.
Epilincomycin
5.
Lincocin
6.
Lincomycin A
7.
Lincomycin Hydrochloride
8.
Lincomycin Monohydrochloride
9.
Lincomycin Monohydrochloride, (2S-cis)-Isomer
10.
Lincomycin Monohydrochloride, (L-threo)-Isomer
11.
Lincomycin Monohydrochloride, Hemihydrate
12.
Lincomycin, (L-threo)-Isomer
13.
Hemihydrate Lincomycin Monohydrochloride
External Link(s)
MeSHD008034
PubChem Compound657256
6419944
CHEMBLCHEMBL1405894
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypotensionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
2TachycardiaFAERS: 2US FAERS
3VomitingFAERS: 2
Canada Vigilance: 6
Canada Vigilance
US FAERS
4AbasiaFAERS: 1US FAERS
5AngioedemaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
6AstheniaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
7AsthmaFAERS: 1US FAERS
8Burning sensationFAERS: 1US FAERS
9DeafnessFAERS: 1US FAERS
10DizzinessFAERS: 1US FAERS
11Drug administered at inappropriate siteFAERS: 1US FAERS
12Eye BurnsFAERS: 1US FAERS
13Facial paralysisFAERS: 1US FAERS
14Feeling abnormalFAERS: 1US FAERS
15HypothyroidismFAERS: 1US FAERS
16Inadequate analgesiaFAERS: 1US FAERS
17MalaiseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
18Medication ErrorFAERS: 1US FAERS
19ParesisFAERS: 1US FAERS
20PresyncopeFAERS: 1US FAERS
21Rash erythematousFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
22SchizophreniaFAERS: 1US FAERS
23Sensorimotor disorderFAERS: 1US FAERS
24StrabismusFAERS: 1US FAERS
25SwellingFAERS: 1US FAERS
26SyncopeFAERS: 1US FAERS
27Toxic Epidermal NecrolysisFAERS: 1US FAERS
28UrticariaFAERS: 1
Canada Vigilance: 8
Canada Vigilance
US FAERS
29nervous system disorderFAERS: 1US FAERS
30Abdominal PainCanada Vigilance: 4Canada Vigilance
31AgitationCanada Vigilance: 1Canada Vigilance
32BlepharitisCanada Vigilance: 2Canada Vigilance
33ChillsCanada Vigilance: 1Canada Vigilance
34ColitisCanada Vigilance: 1Canada Vigilance
35CyanosisCanada Vigilance: 1Canada Vigilance
36DysmorphismCanada Vigilance: 1Canada Vigilance
37EpistaxisCanada Vigilance: 1Canada Vigilance
38Erythema MultiformeCanada Vigilance: 2Canada Vigilance
39ErythemaCanada Vigilance: 6Canada Vigilance
40FlushingCanada Vigilance: 1Canada Vigilance
41GastroenteritisCanada Vigilance: 1Canada Vigilance
42HypersensitivityCanada Vigilance: 2Canada Vigilance
43HyperventilationCanada Vigilance: 1Canada Vigilance
44LymphadenopathyCanada Vigilance: 1Canada Vigilance
45NauseaCanada Vigilance: 3Canada Vigilance
46NervousnessCanada Vigilance: 1Canada Vigilance
47Peptic UlcerCanada Vigilance: 1Canada Vigilance
48ProctitisCanada Vigilance: 1Canada Vigilance
49PruritusCanada Vigilance: 5Canada Vigilance
50PurpuraCanada Vigilance: 1Canada Vigilance
51Rectal tenesmusCanada Vigilance: 1Canada Vigilance
52SinusitisCanada Vigilance: 1Canada Vigilance
53Stevens-Johnson SyndromeCanada Vigilance: 1Canada Vigilance
54ThrombocytopeniaCanada Vigilance: 1Canada Vigilance
55Uterine spasmCanada Vigilance: 1Canada Vigilance
56VasculitisCanada Vigilance: 1Canada Vigilance
57VertigoCanada Vigilance: 1Canada Vigilance
58Vulvovaginal pruritusCanada Vigilance: 1Canada Vigilance
59Weight decreasedCanada Vigilance: 1Canada Vigilance
60pseudomembranous colitisCanada Vigilance: 4Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.